No Data
No Data
Accuray Loses US$24m Market Value But Insiders See Windfall Of US$23k
ARAY Stock Falls Despite Positive Data of CyberKnife in Treating BSM
Accuray's CyberKnife System Offers Promising Outcomes For Brainstem Metastases, Highlighting Safety And Precision
Accuray Reports New Data From Multicenter Analysis of SRS and FSRT
Accuray Announces Departure of Senior VP Michael Hoge
Big Pharma Pushes To Revise Biden-era Medicare Drug Price Negotiation Law Under Trump